Clinical trial
PREVENT ALL ALS - Longitudinal Biomarker Study for Participants Who Are Genetically at Risk for Amyotrophic Lateral Sclerosis (ALS)
NCT06581861 is registered in ClinicalTrials.gov with St. Joseph's Hospital and Medical Center, Phoenix as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- PREVENT ALL ALS - Longitudinal Biomarker Study for Participants Who Are Genetically at Risk for Amyotrophic Lateral Sclerosis (ALS)
- Lead sponsor
- St. Joseph's Hospital and Medical Center, Phoenix
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- July 25, 2024
- Completion date
- July 25, 2029
- Enrollment
- 600 (estimated)
- Sites
- 32
Conditions
As the registry lists them; a condition with its own page is linked.